Effects of Epidermal Growth Factor Receptor Inhibitor Therapy in the Skin of Cancer Patients

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2006
RATIONALE: Studying samples of tissue and blood in the laboratory from patients with cancer receiving epidermal growth factor receptor (EGFR) inhibitors may help doctors understand the effects of EGFR inhibitor therapy in the skin. PURPOSE: This laboratory study is looking at the effects of EGFR inhibitors in the skin of cancer patients.
Epistemonikos ID: 65b94fa6812a20debedc7a80a5d72d6191afd5ad
First added on: May 04, 2024